Alcohol Consumption and Statin Therapy
Safety and Recommendations
- Moderate alcohol consumption, defined as no more than 1 drink per day for women and 2 drinks per day for men, is generally compatible with statin therapy in patients without liver disease, according to the American Heart Association 1
- Heavy alcohol consumption, defined as more than 4 drinks on any day or more than 14 drinks per week in men, or more than 3 drinks on any day or 7 drinks per week in women, should be avoided as it is a risk factor for chronic liver disease, as stated by the American Gastroenterological Association 2, 3
- Patients with very high triglyceride levels should completely abstain from alcohol to reduce risk of pancreatitis, as recommended by the American College of Cardiology 4, 5
Liver Considerations
- Statins are safe in patients with stable liver disease, including non-alcoholic fatty liver disease (NAFLD), according to the European Association for the Study of the Liver 6
Benefits of Statins in Patients with Liver Disease
- Statins may actually improve liver biochemistries in patients with NAFLD/NASH (non-alcoholic steatohepatitis), as reported by the American Association for the Study of Liver Diseases 2, 3
Special Considerations for Alcohol and Statin Use
- The British Association for the Study of the Liver recommends regular reassessment of alcohol consumption for patients with NAFLD who take statins 7
- Patients with NAFLD and cirrhosis should be strongly advised to abstain from alcohol completely, as recommended by the European Association for the Study of the Liver 7, 8
Practical Guidance
- The American Heart Association advises patients that moderate alcohol consumption is generally acceptable with statin therapy if they have no underlying liver disease 1
- The American Gastroenterological Association emphasizes that heavy alcohol use should be avoided, particularly in patients with existing liver conditions 2, 3
- The British Association for the Study of the Liver strongly recommends minimizing or abstaining from alcohol to reduce the risk of disease progression in patients with NAFLD/NASH 7, 8